Who founded Cytotronics?

Cytotronics was founded by Jeffrey Abbott, Vince Wu, Duane Sword, Donhee Ham, Hongkun Park, Vince (Wenxuan) Wu in 2020.

Who are Cytotronics's investors?

Cytotronics's investors include Anzu Partners, LYFE Capital, Bantam Group, Draper Associates, BoxOne Ventures.

How much funding has Cytotronics raised?

Cytotronics has disclosed $13.5M raised across 1 round.

Where is Cytotronics headquartered?

Cytotronics is headquartered in Boston, US.

Cytotronics

Boston, US · Founded 2020 · Delaware corporation · 8 employees on LinkedIn · 5 known investors

Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system. It serves cell biologists working in therapeutic areas such as vascular biology, stem cell differentiation, cardiovascular and neurological disease, and oncology.

Biotech Deep Tech Semiconductors

Founders & leadership

Jeffrey AbbottCo-Founder & CEO

Vince WuCo-Founder & CTO

Duane SwordinCo-Founder & CBO

Donhee HamScientific Co-Founder

Hongkun ParkScientific Co-Founder

Vince (Wenxuan) WuinCo-founder & CTO (Acquired by Axion Biosystems)2021–2025

Wenxuan WuNamed on SEC filing

Board

Sameer RohatgiBoard director

Jenna AbelliBoard director

Douglas KahnBoard director

Investors · 5

Anzu Partners✓ verifiedBillerica

LYFE Capital✓ verifiedMenlo Park

Bantam GroupWestwood

Draper AssociatesSan Mateo · $500K – $5M

BoxOne VenturesreportedMontréal · $500K

Reported raises · per SEC filings

Form D private placements

$13.5M disclosed across 1 round · 2024

▶$13.5MraisedOct 2024 · 10 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Sameer RohatgiDirector
Jeffrey AbbottExecutive Officer, Director
Douglas KahnDirector
Wenxuan WuExecutive Officer, Director
Jenna AbelliDirector

Offering amount: $13.5M
Amount sold: $13.5M
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Molecular Devices17 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.

Companies competing with Cytotronics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cytotronics do?: Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system. It serves cell biologists working in therapeutic areas such as vascular biology, stem cell differentiation, cardiovascular and neurological disease, and oncology.
Who founded Cytotronics?: Cytotronics was founded by Jeffrey Abbott, Vince Wu, Duane Sword, Donhee Ham, Hongkun Park, Vince (Wenxuan) Wu in 2020.
Who are Cytotronics's investors?: Cytotronics's investors include Anzu Partners, LYFE Capital, Bantam Group, Draper Associates, BoxOne Ventures.
How much funding has Cytotronics raised?: Cytotronics has disclosed $13.5M raised across 1 round.
Where is Cytotronics headquartered?: Cytotronics is headquartered in Boston, US.